Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$12.99 - $16.48 $366,473 - $464,933
28,212 New
28,212 $395,000
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $1.56 Million - $2.3 Million
75,597 New
75,597 $1.93 Million
Q2 2022

Aug 12, 2022

SELL
$26.05 - $37.48 $260,500 - $374,799
-10,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$24.46 - $40.92 $244,600 - $409,200
10,000 New
10,000 $353,000
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $4.43 Million - $5.82 Million
-126,584 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $3.95 Million - $6.5 Million
107,284 Added 555.88%
126,584 $6.21 Million
Q2 2021

Aug 12, 2021

BUY
$32.46 - $45.0 $626,478 - $868,500
19,300 New
19,300 $805,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $919M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.